Eduardo Castañón

Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score)

Frédéric Bigot, Eduardo Castañón, Capucine Baldini et al. · European Journal of Cancer · 2017 · 215 citations

Prognostic Evaluation, Autoimmune Disease, Immunotherapy Phase +10

Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study

Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Juan Virizuela Echaburu et al. · Journal of Clinical Oncology · 2015 · 156 citations · Full text

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti–PD-1 for patients with anti–PD-1–refractory tumors

Iván Márquez‐Rodas, Federico Longo, María E. Rodríguez-Ruiz et al. · Science Translational Medicine · 2020 · 80 citations

LBA41 LEAP-005: Phase II study of lenvatinib (len) plus pembrolizumab (pembro) in patients (pts) with previously treated advanced solid tumours

Zarnie Lwin, Carlos Gomez‐Roca, Esma Saâda-Bouzid et al. · Annals of Oncology · 2020 · 72 citations

Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study

Carme Font, Alberto Carmona‐Bayonas, Carmen Beato et al. · European Respiratory Journal · 2016 · 66 citations · Full text